Related Experiment Video
Updated: May 27, 2026
11:52
Evaluation of Antimicrobial Activities of Nanoparticles and Nanostructured Surfaces In Vitro
Published on: April 21, 2023
Antimicrobial acrylic materials with in situ generated silver nanoparticles
James D Oei1, William W Zhao, Lianrui Chu
1Department of Comprehensive Dentistry, Division of Research, University of Texas Health Science Center San Antonio, San Antonio, Texas.
Journal of Biomedical Materials Research. Part B, Applied Biomaterials
|November 22, 2011
Summary
This study developed silver nanoparticle-loaded polymethyl methacrylate (AgNP-PMMA) to combat implant infections. AgNP-PMMA demonstrated broad-spectrum antimicrobial activity and sustained silver ion release, offering a promising solution for preventing resistant bacterial infections.
Area of Science:
- Biomaterials Science
- Infectious Disease Research
- Nanotechnology
Background:
- Polymethyl methacrylate (PMMA) is utilized in cranioplasty and orthopedic bone cement but is susceptible to implant-centered infections.
- Increasing antibiotic resistance in bacteria like Acinetobacter baumannii and MRSA necessitates novel antimicrobial strategies.
- There is a critical need for antimicrobial delivery systems that do not promote further resistance.
Purpose of the Study:
- To engineer a novel antimicrobial implant material by synthesizing silver nanoparticles (AgNPs) directly within PMMA.
- To evaluate the antimicrobial efficacy and ion release characteristics of the developed AgNP-PMMA composite.
Main Methods:
- Silver nanoparticles (AgNPs) were generated in situ within PMMA to create AgNP-PMMA composite materials.
- In vitro release of silver ions (Ag+) from AgNP-PMMA samples was monitored over 28 days.
- Antimicrobial assays were performed against four bacterial strains to assess the efficacy of AgNP-PMMA.
- Mechanical properties, including Durometer-D hardness, modulus, and ultimate transverse strength, were evaluated.
Main Results:
- AgNP-PMMA samples exhibited sustained Ag+ ion release in vitro for over 28 days.
- Antimicrobial assays demonstrated that AgNP-PMMA inhibited 99.9% of tested bacteria, including resistant strains.
- A significant, long-term antibacterial effect was observed beyond the 28-day study period.
- While some AgNP-PMMA groups maintained comparable hardness and modulus to control PMMA, ultimate transverse strength was slightly reduced.
Conclusions:
- AgNP-PMMA exhibits broad-spectrum antimicrobial activity with sustained efficacy, addressing the challenge of implant-centered infections.
- The developed material shows promising mechanical properties comparable to conventional PMMA for orthopedic and cranioplasty applications.
- Ongoing research focuses on optimizing mechanical properties by adjusting AgNP loading and evaluating fatigue performance for clinical translation.
